Table 2. Results for all channel-pair analyses corrected for confounds.

Each row represents two channel-pair results for a given contrast, study, and space combination; uncorrected for multiple comparisons. Electrode placement for each study is shown in Figure 1C. (N: number of participants included in given contrast; ES: effect size; Cohen’s d for group comparison and Pearson’s r for regression; CI: bootstrap 95% confidence interval for the effect size).

No.	Contrast	Study	Space	N	Selected electrodes corrected for confounds
					Pair 1 (F3–F4)				Pair 2 (F7–F8)
					t	p	ES	CI	t	p	ES	CI
1	DvsHC	I	avg	29 vs 22	−2.679	0.010	−0.789	[−1.413,–0.218]	−0.782	0.438	−0.230	[−0.691, 0.288]
2	DvsHC	I	csd	29 vs 22	0.269	0.789	0.079	[−0.501, 0.681]	0.305	0.762	0.090	[−0.404, 0.622]
3	DvsHC	III	avg	27 vs 21	0.204	0.839	0.064	[−0.642, 0.684]	−1.161	0.252	−0.366	[−0.994, 0.310]
4	DvsHC	III	csd	27 vs 21	−0.162	0.872	−0.051	[−0.691, 0.547]	−0.703	0.486	−0.221	[−0.998, 0.558]
5	DvsHC	IV	avg	22 vs 71	0.310	0.757	0.077	[−0.338, 0.504]	0.085	0.933	0.021	[−0.412, 0.450]
6	DvsHC	IV	csd	22 vs 71	0.978	0.331	0.244	[−0.250, 0.816]	−1.484	0.141	−0.370	[−0.842, 0.135]
7	DvsHC	V	avg	24 vs 29	1.862	0.069	0.540	[0.033, 1.044]	1.817	0.075	0.527	[−0.008, 1.101]
8	DvsHC	V	csd	24 vs 29	0.518	0.607	0.150	[−0.415, 0.742]	−0.722	0.474	−0.209	[−0.689, 0.235]
9	SvsHC	II	avg	23 vs 28	0.351	0.728	0.105	[−0.444, 0.746]	−0.654	0.516	−0.196	[−0.883, 0.450]
10	SvsHC	II	csd	23 vs 28	1.293	0.203	0.387	[−0.152, 0.943]	0.035	0.972	0.010	[−0.653, 0.532]
11	SvsHC	III	avg	33 vs 21	−1.169	0.248	−0.350	[−0.946, 0.285]	−1.768	0.084	−0.529	[−1.071, 0.029]
12	SvsHC	III	csd	33 vs 21	−1.382	0.173	−0.414	[−1.086, 0.160]	−1.197	0.237	−0.358	[−0.997, 0.212]
13	SvsHC	IV	avg	21 vs 71	1.058	0.293	0.269	[−0.232, 0.776]	0.466	0.642	0.118	[−0.293, 0.515]
14	SvsHC	IV	csd	21 vs 71	0.739	0.462	0.188	[−0.302, 0.649]	−0.263	0.793	−0.067	[−0.524, 0.483]
15	allReg	I	avg	54	−1.352	0.182	−0.188	[−0.440, 0.078]	−0.349	0.728	−0.049	[−0.369, 0.240]
16	allReg	I	csd	54	−0.431	0.668	−0.061	[−0.313, 0.187]	−0.019	0.985	−0.003	[−0.335, 0.304]
17	allReg	III	avg	91	0.233	0.816	0.025	[−0.156, 0.263]	−1.170	0.245	−0.127	[−0.313, 0.092]
18	allReg	III	csd	91	−0.005	0.996	−0.001	[−0.190, 0.204]	−0.060	0.953	−0.007	[−0.238, 0.224]
19	allReg	IV	avg	116	0.904	0.368	0.085	[−0.088, 0.237]	0.355	0.723	0.034	[−0.139, 0.197]
20	allReg	IV	csd	116	1.461	0.147	0.137	[−0.064, 0.316]	−1.300	0.196	−0.122	[−0.296, 0.059]
21	allReg	V	avg	53	1.685	0.099	0.236	[−0.014, 0.449]	1.544	0.129	0.218	[−0.034, 0.433]
22	allReg	V	csd	53	0.769	0.446	0.110	[−0.148, 0.339]	−0.058	0.954	−0.008	[−0.214, 0.185]
23	DReg	I	avg	29	0.767	0.450	0.152	[−0.324, 0.503]	0.265	0.793	0.053	[−0.452, 0.564]
24	DReg	I	csd	29	−1.273	0.215	−0.247	[−0.588, 0.156]	−0.506	0.617	−0.101	[−0.504, 0.437]
25	DReg	III	avg	27	−0.054	0.958	−0.012	[−0.434, 0.485]	−0.079	0.937	−0.018	[−0.425, 0.346]
26	DReg	III	csd	27	0.055	0.957	0.012	[−0.407, 0.408]	1.375	0.184	0.294	[−0.096, 0.614]
27	DReg	IV	avg	22	1.979	0.063	0.423	[−0.001, 0.719]	−0.062	0.951	−0.015	[−0.409, 0.473]
28	DReg	IV	csd	22	1.761	0.095	0.383	[0.004, 0.674]	−0.269	0.791	−0.063	[−0.538, 0.418]
29	DReg	V	avg	24	0.926	0.366	0.208	[−0.209, 0.565]	−0.707	0.488	−0.160	[−0.571, 0.278]
30	DReg	V	csd	24	0.723	0.478	0.164	[−0.345, 0.554]	0.298	0.769	0.068	[−0.569, 0.735]

DvsHC – diagnosed and healthy controls; SvsHC – sub-clinical and healthy controls; allReg – linear regression for all subjects together; DReg – linear regression for only diagnosed subjects; avg – average reference; csd – current source density.